
Sign up to save your podcasts
Or
Mark Odendahl, Head of US Equity Research, and Brian Abrahams, Head of Biotechnology at RBC Capital Markets have a discussion on how website traffic uncovers insights into the sales of leading biopharmaceutical drugs.
5
1010 ratings
Mark Odendahl, Head of US Equity Research, and Brian Abrahams, Head of Biotechnology at RBC Capital Markets have a discussion on how website traffic uncovers insights into the sales of leading biopharmaceutical drugs.
39 Listeners
12 Listeners
171 Listeners
0 Listeners
3 Listeners
17 Listeners